While insulin therapy has come a long way and there have been a lot of advances in the formulation of insulin and the technology of its delivery, including automated (closed-loop) insulin delivery systems, people with T1D still depend on multiple daily insulin injection or insulin infusions and there is still a lack of effective pharmacological approaches for T1D. This evidence concerns the gene INS and type 1 diabetes mellitus.